Relation of Urinary pH and Specific Gravity with Urolithiasis, in Jalalabad, Nangarhar, Afghanistan
DOI:
https://doi.org/10.53555/bp.v6i6.1323Keywords:
Urine pH, specific gravity, urolithiasis, Anatomical site, Seasonal variation.Abstract
Renal stone disease is, also known as Urolithiasis the most frequent recurrent urological problem-having worldwide distribution. Globally, urolithiasis is the third most common urological disease affecting both males and females. In developed countries, up to 12% of men and 7% of women will suffer from kidney stones in their lifetime, and the prevalence appears to be increasing. This retrospective descriptive study was conducted to determine the effects of urine pH and specific gravity in the formation of urinary stones among ultrasound confirmed Urolithiasis patients who reported to the Departments of Radiology and Biochemistry –Microbiology of Nangarhar Medical University Teaching hospital. Jalalabad, Afghanistan. Data on patient’s age, gender, seasonality, anatomical sites of the stone, biochemical parameters such as urine color, deposit, pH, specific gravity, Albumen, Glucose, Pus cells, Red Blood Cells (RBCs (and crystals were obtained from case records. Nonparametric Kruskal-Wallis test was used to find the mean of specific gravity and pH changed to anatomical location of stone and different seasons. Nonparametric Kruskal-Wallis test showed that there was no statistically significant difference in urine pH and specific gravity in patients with stones in different anatomical sites. On testing, the correlation between pH and specific gravity using spearman’s correlation test showed that there was no statistically significant correlation between pH and specific gravity in urine. The analysis of the effect of seasonality on specific gravity showed that specific gravity during the summer season was comparatively high compared to that in winter. The difference observed was not statistically significant. With regard to pH, during winter the mean pH was high when compared to that in summer. The difference observed was not statistically significant. Comparing specific gravity and pH, the highest mean specific gravity was observed in summer and the highest mean pH in winter. On comparing the mean specific gravity in crystalluric and non-crystalluric patients, an increasing trend was observed from urine with crystalluria. On comparing the mean pH with crystalluria a negative trend was observed, an increased pH for urine without crystals, and a decreased pH for urine with crystals urine.
Downloads
References
2. Asplin JR. Nephrolithiasis: introduction. Semin Nephrol 2008; 28: 97-8.
3. STAMATELOU KK, FRANCIS ME, JONES CA, et al: Time trends in reported prevalence of kidney stones in the United States: 1976–1994.Kidney Int 63:1817–1823, 2003
4. YOSHIDA O, TERAI A, OHKAWA T, OKADA Y: National trend of the incidence of Urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899–1904, 1999.
5. SERIO A, FRAIOLI A: Epidemiology of nephrolithiasis. Nephron 81 (Suppl 1):26–30, 1999
6. FLEGAL KM, CARROLL MD, OGDEN CL, JOHNSON CL: Prevalence and trends in obesity among US adults, 1999–2000. JAMA288:1723– 1727, 2002
7. KOPELMAN PG: Obesity as a medical problem. Nature 404:635–643, 2000
8. WORLDHEALTHORGANIZATION: Obesity: Preventing and Managing a Global Epidemic, Geneva, World Health Organization, 2000, Technical Report Series no. 894
9. GOLDFARB DS: Increasing prevalence of kidney stones in the United States. Kidney Int 63:1951–1952, 2003.
10. NISHIO S, YOKOYAMA M, IWATA H, et al: Obesity as one of the risk factors for Urolithiasis. Nippon Hinyokika Gakkai Zasshi 89:573– 580, 1998
11. CURHAN GC, WILLETT WC, RIMM EB, et al: Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652, 1998
12. SAKHAEE K, ADAMS-HUET B, MOE OW, PAK CY: Pathophysiologic basis for normo uricosuric uric acid nephrolithiasis. Kidney Int 62:971–979, 2002
13. ABATE N, CHANDALIA M, CABO-CHAN AV, et al: The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392, 2004
14. PAK CY, SAKHAEE K, MOE OW, et al: Biochemical profile of stone forming patients with diabetes mellitus. Urology 61:523–527, 2003
15. KHATCHADOURIAN J, PREMINGERGM, WHITSONPA, et al: Clinical and biochemical presentation of gouty diathesis: Comparison of uric acid versus pure calcium stone formation. J Urol 154:1665–1669, 1995
16. PAK CY, SAKHAEE K, PETERSON RD, et al: Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 60:757–761, 2001
17. PAK CY, WATERS O, ARNOLD L, et al: Mechanism for calcium Urolithiasis among patients with hyperuricosuria: Supersaturating of urine with respect to monosodium urate. J Clin Invest 59:426–431, 1977.
18. COE FL, KAVALACH AG: Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 291:1344–1350, 1974
19. PAK CY, ARNOLD LH: Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp BiolMed149:930–932,1975
20. COE FL, STRAUSS AL, TEMBE V, LE DUN S: Uric acid saturation in calcium nephrolithiasis. Kidney Int 17:662–668, 1980
21. MOE OW, ABATE N, SAKHAEE K: Pathophysiology of uric acid nephrolithiasis. Endocrinol Metab Clin North Am 31:895–914, 2002.
22.Stamatiou KN, Karanasion VI, Lacrois RE, Kavouras NG, Papadimitriou VT, Chlopsios C, et al. Prevalence of urolithiasis in rural Thebes, Greece. Rural Remote Health. 2006; 6:610.
23.Kim H, Jo MK, Kwak C, Park SK, Yoo KY, Kang D, et al. Prevalence and epidemiologic characteristics of Urolithiasis in Seoul, Korea. Urology. 2002; 59:517-21.
24.Lee YH, Huang WC, Tsai JY, Lu CM, Chen WC, Lee MH, et al. Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int. 2002; 68:172-7.
25.Ghafoor M, Majeed I, Nawaz A, Al-Salem A, Halim A. Urolithiasis in the pediatric age group. Ann Saudi Med. 2003; 23:201-5.
26. Pinduli I, Spivacow FR, del Valle EE, et al. Prevalence of Urolithiasis in the autonomous city of Buenos Aires, Argentina. Urol Res 2006; 34: 8-11.
27.Anderson RA. A complementary approach to Urolithiasis prevention. World J Urol 2002; 20: 294-301.
28. Sakhaee K, Maalouf NM, Sinnott B. Kidney stones: patho¬genesis, diagnosis, and management. J Clin Endocrinol Metab 2012; 97: 1847-60.
29.Hiatt RA, Dales LG, Friedman GD, Hunkeler EM. Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol. 1982; 115:255-65.
30.Unal D, Yeni E, Verit A, Karatas OF. Prognostic factors effecting on recurrence of urinary stone disease: a multivariate analysis of everyday patient parameters. Int Urol Nephrol. 2005; 37:447-52.
31.Cameron MA, Charles YC. Approach to the patient with the first episode of nephrolithiasis. Clinical Reviews in Bone and Mineral Metabolism. 2004; 2:265-78.
32. Kumar A. Urine examination for calculogenic crystals--a newer approach using refrigeration. Trop Doct. 2004; 34:153-5
33. National Aeronautics and Space Administration. Evidence book. Risk of renal stone formation. Houston: Lyndon B Johnson Space Center; 2008.
34. Robertson WG, Peacock M. The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria. Nephron. 1980; 26:105-10.
35. Tiselius HG. Risk formulas in calcium oxalate urolithiasis. World J Urol. 1997; 15:176-85.
36.Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int. 2005; 67:1934-43.
37..McCann JA, Schilling RN. Professional guide to diseases. 8th ed. London: Lippincott Williams and Wilkins Publishers; 2005.
38.Basler J, Ghobriel A. Bladder Stones. eMedicine [Online]. 2004- [Cited 4 April 2010]. Available from: URL: http://www.arabmedmag.com/issue-30-04-2005/urology/main03.htm.
39. Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, et al. Nucleation of calcium oxalate crystals by albumin: Involvement in the prevention of stone formation. Kidney Int. 1999; 55:1776-86.
39. Sperling O. Uric acid nephrolithiasis. In: Wickham EA, Buck AC, editors. Renal tact stone - Metabolic basis and clinical practice. Edinburgh: Churchill Livingstone; 1990. p. 349-65.
40. Ansari MS, Gupta N P. Impact of socioeconomic status and management of urinary stone disease. Urol Int. 2003;70:255-61.
41. Litwin MS, Saigal CS. Urologic Diseases in America. Washington, DC, US Government Publishing Office, NIH Publication No. 04-5512, 2004; 283-316.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 International Journal For Research In Biology & Pharmacy (ISSN: 2208-2093)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In consideration of the journal, Green Publication taking action in reviewing and editing our manuscript, the authors undersigned hereby transfer, assign, or otherwise convey all copyright ownership to the Editorial Office of the Green Publication in the event that such work is published in the journal. Such conveyance covers any product that may derive from the published journal, whether print or electronic. Green Publication shall have the right to register copyright to the Article in its name as claimant, whether separately
or as part of the journal issue or other medium in which the Article is included.
By signing this Agreement, the author(s), and in the case of a Work Made For Hire, the employer, jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere, and is not being considered for publication elsewhere in any form, except as provided herein. Each author’s signature should appear below. The signing author(s) (and, in
